GHP Specialty Care (GHP.ST) Stock Analysis & AI Equity Report
GHP Specialty Care (GHP.ST) overview
GHP Specialty Care (GHP.ST) stock analysis and AI equity research. For the latest completed financial year, 2021, GHP Specialty Care reported revenue of SEK 1,468m and operating profit of SEK 81.9m; the year-end share price was N/A and market capitalisation was N/A. GHP Specialty Care is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get GHP Specialty Care's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-09-04. Data will be refreshed during report generation.
About GHP Specialty Care
GHP Specialty Care AB operates specialist clinics in selected diagnostic areas, providing healthcare services focused on patients with specific conditions. Its model centers on clinical specialization and collaboration with doctors and medical staff, with operations designed to improve efficiency and quality. The company also develops care processes and service models for defined patient groups.
Generate the GHP Specialty Care report
GHP Specialty Care is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for GHP Specialty Care and represent the latest completed financial year (2021). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.